Sara Cingarlini

Dr. Sara Cingarlini


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2017 in Nature
Verified
Journal Article
Closed access
AIAustralian Pancreatic Cancer Genome Initiative
Australian Pancreatic Cancer Genome Initiative
ASAldo Scarpa
Aldo Scarpa
DCDavid K. Chang
David K. Chang
Katia NonesKatia Nones
Katia Nones
VCVincenzo Corbo
Vincenzo Corbo
SGSean M. Grimmond
Sean M. Grimmond

30 October 2003 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
PSPaolo Serafini
Paolo Serafini
CSCarmela De Santo
Carmela De Santo
IMIlaria Marigo
Ilaria Marigo
SCSara Cingarlini
Sara Cingarlini
LDLuigi Dolcetti
Luigi Dolcetti
VBVincenzo Bronte
Vincenzo Bronte

1 April 2010 in Vaccine
Verified
Journal Article
Closed access
MMMatteo Martini
Matteo Martini
MTMaria Grazia Testi
Maria Grazia Testi
MPMatteo Pasetto
Matteo Pasetto
MPMaria Cristina Picchio
Maria Cristina Picchio
Giulio InnamoratiGiulio Innamorati
Giulio Innamorati
SSSilvia Sartoris
Silvia Sartoris

20 October 2014 in Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
MSMaria Scardoni
Maria Scardoni
EVEmanuele Vittoria
Emanuele Vittoria
MVMarco Volante
Marco Volante
BRBorislav Rusev
Borislav Rusev
SBSamantha Bersani
Samantha Bersani
ASAldo Scarpa
Aldo Scarpa
Background: Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract are rare neoplasms characterized by coexisting exocrine and neuroendocrine neoplastic components. MANECs' histogenetic classification and molecular characterization remain unclear, significantly affecting the identification of innovative therapeutic options for these tumors. Methods: The exocrine and neuroendocrine components of 6 gastrointestinal MANECs were microdissected and subjected to the simultaneous mutation assessment in selected regions of 54 cancer-associated genes using Ion Torrent semiconductor-based next-generation sequencing. Sanger sequencing and immunohistochemistry were used as validation of the mutational status. Results: A total of 20 driver gene somatic mutations were observed among the 12 neoplastic components investigated. In 11 of 12 (91.7%) samples, at least one mutation was detected; 7 samples (58.3%) were found to have multiple mutations. TP53 gene mutations were the most frequent genetic alterations observed in the series, occurring in 11/12 samples (91.7%). Somatic mutations in other genes were detected at lower frequencies: ATM, CTNNB1, ERBB4, JAK3, KDR, KRAS, RB1. Conclusions: Five of the 6 MANECs presented an overlapping mutational profile in both components, suggesting a monoclonal origin of the two MANEC components.

4 October 2016 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
MSMaddalena Sansovini
Maddalena Sansovini
SSStefano Severi
Stefano Severi
AIAnnarita Ianniello
Annarita Ianniello
SNSilvia Nicolini
Silvia Nicolini
LFLorenzo Fantini
Lorenzo Fantini
GPGiovanni Paganelli
Giovanni Paganelli

1 January 2015 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
GBGiovanni Butturini
Giovanni Butturini
IDIsacco Damoli
Isacco Damoli
LCLorenzo Crepaz
Lorenzo Crepaz
GMGiuseppe Malleo
Giuseppe Malleo
GMGiovanni Marchegiani
Giovanni Marchegiani
CBClaudio Bassi
Claudio Bassi